Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BCAR3 Protein (Myc-DYKDDDDK Tag)

BCAR3 Origine: Humain Hôte: HEK-293 Cells Recombinant > 80 % as determined by SDS-PAGE and Coomassie blue staining AbP, STD
N° du produit ABIN2715176
  • Antigène Voir toutes BCAR3 Protéines
    BCAR3 (Breast Cancer Anti-Estrogen Resistance 3 (BCAR3))
    Type de proteíne
    Recombinant
    Origine
    • 3
    • 1
    Humain
    Source
    • 2
    • 1
    • 1
    HEK-293 Cells
    Purification/Conjugué
    Cette BCAR3 protéine est marqué à la Myc-DYKDDDDK Tag.
    Application
    Antibody Production (AbP), Standard (STD)
    Attributs du produit
    • Recombinant human BCAR3 / SH2D3B protein expressed in HEK293 cells.
    • Produced with end-sequenced ORF clone
    Pureté
    > 80 % as determined by SDS-PAGE and Coomassie blue staining
    Top Product
    Discover our top product BCAR3 Protéine
  • Indications d'application
    Recombinant human proteins can be used for:
    Native antigens for optimized antibody production
    Positive controls in ELISA and other antibody assays
    Commentaires

    The tag is located at the C-terminal.

    Restrictions
    For Research Use only
  • Concentration
    50 μg/mL
    Buffer
    25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
    Stock
    -80 °C
    Stockage commentaire
    Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
  • Antigène
    BCAR3 (Breast Cancer Anti-Estrogen Resistance 3 (BCAR3))
    Autre désignation
    Bcar3,sh2d3b (BCAR3 Produits)
    Synonymes
    NSP2 Protein, SH2D3B Protein, AI131758 Protein, AND-34 Protein, BCAR3 Protein, breast cancer anti-estrogen resistance 3 Protein, breast cancer anti-estrogen resistance 3 L homeolog Protein, BCAR3 Protein, Bcar3 Protein, bcar3 Protein, bcar3.L Protein
    Sujet
    Breast tumors are initially dependent on estrogens for growth and progression and can be inhibited by anti-estrogens such as tamoxifen. However, breast cancers progress to become anti-estrogen resistant. Breast cancer anti-estrogen resistance gene 3 was identified in the search for genes involved in the development of estrogen resistance. The gene encodes a component of intracellular signal transduction that causes estrogen-independent proliferation in human breast cancer cells. The protein contains a putative src homology 2 (SH2) domain, a hall mark of cellular tyrosine kinase signaling molecules, and is partly homologous to the cell division cycle protein CDC48. Multiple transcript variants encoding different isoforms have been found for this gene.
    Poids moléculaire
    92.4 kDa
    NCBI Accession
    NP_003558
Vous êtes ici:
Support technique